A Negative EV Opportunity - Sera Prognostics Has A Chance To Become Standard Of Care In Preterm Birth Risk ScreeningSeeking Alpha • 08/10/22
Sera Prognostics, Inc. (SERA) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 08/03/22
Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2022 Financial Results on August 10PRNewsWire • 07/28/22
SERA PROGNOSTICS TO PRESENT AT 42nd ANNUAL WILLIAM BLAIR GROWTH STOCK CONFERENCEPRNewsWire • 06/06/22
SERA PROGNOSTICS ANNOUNCES PUBLICATION OF DATA DEMONSTRATING IMPROVED PERFORMANCE OF ITS PRETRM® TEST WITH MORE PRECISE GESTATIONAL AGEPRNewsWire • 05/19/22
SERA PROGNOSTICS PRESENTS DATA DEMONSTRATING THE HEALTH AND ECONOMIC BENEFIT OF PRETRM® TESTING AT ISPOR ANNUAL MEETINGPRNewsWire • 05/18/22
Sera Prognostics, Inc. (SERA) CEO Greg Critchfield on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/15/22
SERA PROGNOSTICS AND NEWBORN FOUNDATION PARTNER TO REDUCE RISKS ASSOCIATED WITH PRETERM BIRTH AND IMPROVE HEALTH EQUITY THROUGH THE "EVERY MOTHER, EVERY BABY" PROJECTPRNewsWire • 05/05/22
Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2022 Financial Results on May 10PRNewsWire • 05/02/22
SERA PROGNOSTICS ANNOUNCES THE APPOINTMENT OF DR. JANE F. BARLOW TO THE SERA PROGNOSTICS BOARDPRNewsWire • 04/12/22
Sera Prognostics, Inc. (SERA) CEO Gregory Critchfield on Q4 2021 Earnings Call TranscriptSeeking Alpha • 03/30/22
Sera Prognostics Presents Data Demonstrating Prediction of Preeclampsia Utilizing Protein Biomarker and Clinical Factors at SRI Annual MeetingPRNewsWire • 03/18/22
Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2021 Financial Results on March 29PRNewsWire • 03/18/22
SERA PROGNOSTICS ANNOUNCES NEW AGREEMENT WITH MULTIPLAN, EXPANDING PATIENT ACCESS TO THE PRETRM® TESTPRNewsWire • 02/01/22
Sera Prognostics Announces Pricing For PreTRM® Test, The Only Broadly Validated Blood Test To Assess Risk Of Preterm BirthPRNewsWire • 12/02/21
Sera Prognostics Announces Publication Of Data Confirming The Performance Of The IBP4/SHBG Biomarkers In Diverse Non-U.S. PopulationsPRNewsWire • 12/01/21
Sera Prognostics Announces The Appointment Of Sandra A.J. Lawrence To The Sera Prognostics BoardPRNewsWire • 11/30/21
Sera Prognostics Appoints Woodrow Myers, MD, MBA As Advisor Of Public And Political AffairsPRNewsWire • 11/04/21